Format

Send to

Choose Destination
Rheumatol Int. 2017 May;37(5):695-703. doi: 10.1007/s00296-017-3657-x. Epub 2017 Mar 10.

High-sensitive CRP as a predictive marker of long-term outcome in juvenile idiopathic arthritis.

Author information

1
Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital, Rigshospitalet, Denmark. mikel@dadlnet.dk.
2
Department of Pediatrics, Naestved Hospital, Region Zealand, Denmark. mikel@dadlnet.dk.
3
Institute for Inflammation Research, Copenhagen University Hospital, Rigshospitalet, Denmark. mikel@dadlnet.dk.
4
Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital, Rigshospitalet, Denmark.
5
Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark.
6
Department of Pediatrics, University Hospital of North Norway, Tromsø, Norway.
7
Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
8
Department of Pediatrics, University of Gothenburg, Gothenburg, Sweden.
9
Department of Laboratory Medicine, Children's and Women's Health, Norwegian University of Science and Technology, Trondheim, Norway.
10
Department of Pediatrics, St. Olavs Hospital, Trondheim, Norway.
11
Institute for Inflammation Research, Copenhagen University Hospital, Rigshospitalet, Denmark.

Abstract

To evaluate whether C-reactive protein (CRP), including variation within the normal range, is predictive of long-term disease outcome in Juvenile Idiopathic Arthritis (JIA). Consecutive patients with newly diagnosed JIA were included prospectively from defined geographic areas of the Nordic countries from 1997 to 2000. Inclusion criteria were availability of a baseline serum sample within 12 months after disease onset and 8-year clinical assessment data. Systemic onset JIA was not included. CRP was measured by high-sensitive ELISA (detection limit of 0.2 mg/l). One hundred and thirty participants with a median follow-up time of 97 months (range 95-100) were included. At follow-up, 38% of the patients were in remission off medication. Absence of remission was associated with elevated level of CRP at baseline (odds ratio (OR) 1.33, confidence interval (CI) 1.08-1.63, p = 0.007). By applying a cutoff at the normal upper limit (>10 mg/l), the risk of not achieving remission was increased to an OR of 8.60 (CI 2.98-24.81, p < 0.001). Variations of CRP within the normal range had no predictive impact on disease activity at follow-up. Baseline levels of ESR were available in 80 patients (61%) and elevated ESR was associated with absence of remission in a multivariable logistic regression analysis (OR 2.32, CI 1.35-4.00, p = 0.002). This results of this study indicate that baseline CRP concentrations above 10 mg/l are predictive of a poor outcome at 8-year follow-up. We could not demonstrate any predictive value of CRP variations within the normal range.

KEYWORDS:

Arthritis; Erythrocyte sedimentation rate; Follow-up; High-sensitive CRP; Juvenile idiopathic

PMID:
28283733
DOI:
10.1007/s00296-017-3657-x
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center